Furthermore, one of the non-small cell lung cancer fusion gene, EML4-ALK, which activates ALK kinase and contributes to poor prognosis, derives from the circRNA-circ F-EA, which can be detected in the plasma of patients who harbored the EML4-ALK fusion gene [45]. The gene discussed is ALK; the disease is non-small cell lung carcinoma.